Table S1.
AE profiles of CMAB008 and Remicade
| Multiple-dose group CMAB008
|
Multiple-dose group Remicade31
|
|
|---|---|---|
| 3 mg/kg (n=9) | 1, 3, 10 mg/kg (n=87) | |
| Any AE | 4 | 46 |
| Rash | 0 | 6 |
| Headache | 0 | 11 |
| Pharyngitis | 0 | 6 |
| Rhinitis | 0 | 6 |
| Diarrhea | 0 | 8 |
| Cough | 0 | 5 |
| Nausea | 1 | 0 |
| Upper respiratory tract infection | 0 | 4 |
| Urinary tract infection | 0 | 0 |
| RBC decrease | 1 | 0 |
| WBC decrease | 1 | 0 |
| Hb decrease | 1 | 0 |
| SAE | 0 | 5 |
Abbreviations: AE, adverse event; RBC, red blood cell; SAE, serious AE; WBC, white blood cell.